Back to top
more

Pfizer (PFE)

(Real Time Quote from BATS)

$24.24 USD

24.24
27,326,391

+0.31 (1.30%)

Updated Aug 7, 2025 01:48 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (87 out of 246)

Industry: Large Cap Pharmaceuticals

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Stock Market News for Nov 18, 2024

by Zacks Equity Research

Wall Street continues its decline on Friday following the Fed Chairman???s hawkish statement on rate cut.

Andrew Rocco headshot

Trump Taps RFK for HHS: Time to Avoid Biotech?

by Andrew Rocco

With Trump's appointment of Robert F. Kennedy Jr. as the secretary of Health and Human Services, the biotech industry has more questions than answers. Stock Strategist Andrew Rocco explains.

Zacks Equity Research

Kodiak Q3 Loss Narrower Than Expected, Pipeline Development in Focus

by Zacks Equity Research

KOD reports a narrower-than-expected loss for the third quarter of 2024. The company provides updates regarding its pipeline development plans.

Zacks Equity Research

Pfizer (PFE) is a Top-Ranked Value Stock: Should You Buy?

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Equity Research

Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It

by Zacks Equity Research

Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Sundeep Ganoria headshot

Vaccine Stocks Fall After Trump Selects RFK Jr. to Lead HHS

by Sundeep Ganoria

President-elect Donald Trump picks Robert F. Kennedy Jr., a prominent vaccine skeptic, as the next health secretary of the HHS.

Kinjel Shah headshot

Buy These 5 Price-to-Book Value Stocks in November

by Kinjel Shah

The P/B ratio helps to identify low-priced stocks with high growth prospects. PFE, GM, GBX, ITRI and STNE are some such stocks.

Zacks Equity Research

Down -11.04% in 4 Weeks, Here's Why You Should You Buy the Dip in Pfizer (PFE)

by Zacks Equity Research

Pfizer (PFE) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Zacks Equity Research

Zacks.com featured highlights include StoneCo, Skechers, Pfizer and General Motors

by Zacks Equity Research

StoneCo, Skechers, Pfizer and General Motors have been highlighted in this Screen of The Week article.

Derek Lewis headshot

3 Stocks Seeing Insider Buys: CNC, PFE, BMY

by Derek Lewis

Investors can see insider buys as an overall net positive concerning the longer-term outlook for a stock.

Sumit Singh headshot

Build a Balanced Portfolio With 4 Top Value Stocks as Markets Surge

by Sumit Singh

Value investing is essentially about selecting stocks that are cheap but fundamentally sound. STNE, SKX, PFE and GM boast a low P/CF ratio.

Zacks Equity Research

Should Value Investors Buy Pfizer (PFE) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Down -9.77% in 4 Weeks, Here's Why You Should You Buy the Dip in Pfizer (PFE)

by Zacks Equity Research

Pfizer (PFE) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Ekta Bagri headshot

Bristol Myers Stock Trading Near 52-Week High: Time to Buy or Sell?

by Ekta Bagri

BMY has been having a good run for the past three months. The stock recently touched a 52-week high. We believe there is more room for growth, and any dip in share price can be used as a buying opportunity.

Zacks Equity Research

Zacks.com featured highlights include Alibaba Group, Pfizer, Virtu Financial, Leidos and Brinker International

by Zacks Equity Research

Alibaba Group, Pfizer, Virtu Financial, Leidos and Brinker International are part of the Zacks Screen of the Week article.

Andrew Rocco headshot

5 Industries to Watch in a Trump Administration

by Andrew Rocco

Equities usually rise regardless of who assumes the White House. However, savvy, active investors understand the importance of analyzing specific industries under a new administration.

Urmimala Biswas headshot

5 PEG-Based GARP Stocks to Buy Amid Election Week Volatility

by Urmimala Biswas

Here are five stocks with a discounted PEG ratio, BABA, PFE, VIRT, LDOS and EAT, suitable for GARP investors.

Rajani Lohia headshot

5 Low Price-to-Sales Stocks to Craft a Rewarding Investment Portfolio

by Rajani Lohia

The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like GIII, BTU, JAKK, GBX and PFE hold promise.

Zacks Equity Research

PFE or NVO: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

PFE vs. NVO: Which Stock Is the Better Value Option?

Zacks Equity Research

Is Novartis (NVS) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Sweta Killa headshot

Stocks and ETFs in Focus as Americans Head to Polls

by Sweta Killa

Let's discuss the sectors and ETFs that are the potential gainers or losers as Americans head to the polls, which indicate a tight race between Harris and Trump.

Sundeep Ganoria headshot

Should Moderna Stock Be in Your Portfolio Pre-Q3 Earnings?

by Sundeep Ganoria

When MRNA reports third-quarter earnings, investors will likely focus on the sales performance of its recently approved RSV vaccine, mResvia.

Kinjel Shah headshot

Buy, Sell or Hold Pfizer Stock After Q3 Earnings Beat, Guidance Boost?

by Kinjel Shah

Those who own Pfizer's stock may stay invested to see how Pfizer's new growth drivers perform.

Zacks Equity Research

Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know

by Zacks Equity Research

Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Kinjel Shah headshot

Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY's Q3 Earnings in Focus

by Kinjel Shah

LLY, MRK, PFE, ABBV and NVS announce report third-quarter results.